HT RIBO-SEQ

High-throughput ribosome
profiling in a 96-well plate

Profiles up to 96 conditions on one plate.
Start from just 10,000 cells per well.

Measure what cells translate after treatment with your mRNA, ASO, siRNA, biologic or RNA-targeting small molecule. Timepoints and replicates run side by side in a single batch, so you can use translation data to triage hits, study mechanism of action and inform early safety decisions.

How it works

You seed and treat your cells in a 96-well plate and send us the frozen lysate on dry ice. If you’d rather skip the lysis step, we’re happy to take care of that for you. After in-lysate digestion step, ribosome footprints are barcoded directly inside the intact ribosomes. With no ribosome purification or gel cutting, samples are pooled early and processed together from that point on. At the end, you receive a report and our scientists walk you through the results!

HT Ribo-Seq is built on Immagina's RiboWich technology (Bruno et al., bioRxiv 2025)

HT Ribo-Seq at a glance

Samples per plate up to 96
Input per well ~10,000 cells
Sequencing depth ~20 M reads per sample
Input vs conventional Ribo-seq ~700× less
In-frame CDS P-sites 72.2% vs 52.0% with conventional Ribo-seq, on HEK cells

Applications in drug discovery


Built for pharma and biotech teams developing RNA therapeutics (mRNA, ASO, siRNA), biologics and small molecules targeting RNA.

Toxicity studies

Spot translational stress before it becomes a liability.

HT Ribo-Seq compares compounds and doses on one plate and flags stress-response activation (ISR, ER stress), ribosome stalling or global translation shutdown at hit and lead stage. In our validation data it picked up stress genes such as HSPA5, HSP90B1 and SQSTM1.

Dose-response titration

Measure the dose response in translation itself.

A full design of concentrations × timepoints × replicates fits on one plate and runs as one batch. In an eGFP mRNA dose series, footprints rose over a ~60-fold dose range in line with transcript input. eGFP was the only gene that changed, so the signal was specific to the transcript.

Pathway analysis and translation efficiency

Understand mechanism from the same wells.

Running HT Ribo-Seq and RNA-seq on the same well gives translation efficiency, which tells you whether a drug acts on mRNA levels, on translation, or both. Pathway analysis then groups the changed genes: in a TGFβ fibroblast model, 506 genes changed and epithelial–mesenchymal transition was the top pathway.

Also suited to

dark proteome exploration mrna translational engineering translatome biomarker discovery large datasets for ai/ml

Ready to plan your first plate?

Every project starts with a technical design call. Before any plate is seeded, you and Immagina scientists agree on the experimental design together:

  • plate layout and controls (vehicle, positive controls, reference wells)
  • compounds, doses, timepoints and replicates for adequate statistical power
  • cell seeding, cycloheximide treatment, freezing and shipment
  • sequencing depth and optional paired RNA-seq

Settling these up front means no plate is wasted, every condition runs in the same batch, and the results hold up to scrutiny.

Specifications and deliverables

Format96-well plate, up to 96 samples
Input~10,000 cells per wellRange to be determined depending on cell type
Sample typeFrozen cells in plate or frozen lysates
SpeciesHuman, mouse; other annotated genomes on request
Sequencing~20 M reads per sampleDeeper on request
OptionalPaired RNA-seq for translation efficiency
Delivery timeDepending on the project size

You receive 

  • Raw FASTQ, aligned BAM files and gene-level count tables 
  • QC report: footprint length, reading frame, CDS assignment, metagene profiles 
  • Differential translation analysis with volcano plots and heatmaps 
  • Translation efficiency (with paired RNA-seq) and pathway enrichment 
  • Final scientific report and debrief call with our scientists 
  • Customized data analysis based on project needs

FAQ

Can I send frozen samples?

Yes. Frozen cells and frozen lysates give equivalent results (72.0% vs 72.5% in-frame P-sites).

Is my project confidential?

Yes. All projects are handled under confidentiality, and we are happy to work under your CDA.

Do you accept primary cells or tissues?

Validated on eukaryotic cell lines and primary-derived fibroblasts. Other sample types are assessed during the design call.

Can I measure translation efficiency?

Yes, by adding paired RNA-seq from the same wells.

What are the price and timeline?

Both depend on your study design. We provide a quote and timeline once the technical call is done and the project is defined.

Is there a minimum number of samples?

HT-RiboSeq is designed for studies of 48 samples or more. Smaller batches can be arranged for exciting projects.

How do you make sure the data meets quality standards?

Before sequencing your full experiment, we run a short pilot sequencing run to check key quality metrics: footprint length, frame-0 periodicity, CDS assignment and mapped reads. If anything is off, we catch it early, so you don’t spend money on a full run that won’t deliver.